PETER TURECEK,FRIEDRICH SCHEIFLINGER,JUERGEN SIEKMANN,MICHEL CANAVAGGIO
申请号：
PT07865679
公开号：
PT2101821E
申请日:
2007.12.14
申请国别(地区):
PT
年份:
2014
代理人:
摘要：
The present invention relates to a proteinaceous construct comprising plasmatic or recombinant factor VIIa (F VIIa) or biologically active derivatives thereof, which are bound to a carbohydrate moiety comprising 1-4 sialic acid units, wherein the in vivo half-life of the proteinaceous construct is substantially prolonged in the blood of a mammal, as compared to the in vivo half-life of a FVIIa molecule not bound to a carbohydrate moiety. The invention also provides a method for controlling bleeding in a mammal having a bleeding disorder due to functional defects or deficiencies of FVIIa, FVIII, or FIX. The invention also provides a method for controlling bleeding in a mammal during surgery or trauma.
